Cargando…

The Potential Role of Therapeutic Dose of Low Molecular Weight Heparin (LWMH) to Attenuate Hyper-Inflammatory State in Hospitalized COVID-19 Patients

Introduction:The underlying pathophysiology of severe COVID-19 involves cytokine storm syndrome that is associated with an elevation of immunoinflammatory cytokines [1]. This hyper-inflammatory state has been implicated with coagulopathy among severely sick patients with COVID-19. Inflammation and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mughal, Mohsin Sheraz, Kaur, Ikwinder Preet, Jaffery, Ali R., Wang, Chang, Asif, Muhammad, Ricca, Anthony J., Du, Doantrang T., Patton, Chandler D., Granet, Kenneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	332.Anticoagulation and Antithrombotic Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330330/ http://dx.doi.org/10.1182/blood-2020-142109

Ejemplares similares

Edoxaban Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Hospitalized Patients with Atrial Fibrillation and COVID-19 Infection
por: Olivera, Pável E, et al.
Publicado: (2020)

Anticoagulation Management and Outcomes in Covid-19 Patients:a Multi-Center Retrospective Cohort Study
por: Kaur, Jasmeet, et al.
Publicado: (2020)

Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients
por: Ionescu, Filip, et al.
Publicado: (2020)

COVID-19 Associated Coagulopathy: Thrombosis, Hemorrhage and Mortality Rates with an Escalated-Thromboprophylaxis Strategy
por: Daughety, Molly, et al.
Publicado: (2020)

Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group
por: Moraleda, Jose M., et al.
Publicado: (2020)

COVID-19-Associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults with COVID-19
por: Chambers, Isaac, et al.
Publicado: (2020)

Admission Rothman Index, Aspirin, and Intermediate Dose Anticoagulation Effects on Outcomes in COVID-19: A Multi-Site Propensity Matched Analysis
por: Goshua, George, et al.
Publicado: (2020)

Thrombotic Complications in a Canadian Population of Critically Ill Patients with COVID-19
por: Camille, Simard, et al.
Publicado: (2020)

Filter Clotting with Continuous Renal Replacement Therapy in COVID-19
por: Rosovsky, Rachel P., et al.
Publicado: (2020)

The Role of D-Dimer for Optimal Thromboprophylaxis Strategy in Patients with COVID-19
por: Bhoopat, Lantarima, et al.
Publicado: (2020)

Outcomes in COVID-19 Patients on Treatment Dose Anti-Coagulation Compared to Prophylactic Dose Anti-Coagulation
por: Kodama, Rich, et al.
Publicado: (2020)

The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2020)

The Elevation of LIVER Enzymes in Patients with Atrial Fibrillation and COVID-19 Is a Marker of Bad Evolution and Mortality
por: Cerezo Manchado, Juan Jose, et al.
Publicado: (2020)

Evaluation of Antiplatelet and Anticoagulation Therapy in High-Risk COVID-19 Patients
por: Ashraf, Farah, et al.
Publicado: (2020)

Clinical Outcomes in Critically-Ill Patients with COVID-19 Treated with Therapeutic Dose of Anticoagulants for Suspected Thromboembolism
por: Naing, Phyu Thin, et al.
Publicado: (2021)

Targeting the Endothelium in the Treatment of COVID-19 Early Clinical Stages: Results of a Randomized Placebo-Controlled Trial
por: Gonzalez-Ochoa, Alejandro
Publicado: (2021)

Defibrotide Therapy for Sars CoV2 Acute Respiratory Distress Syndrome
por: Yanik, Gregory A, et al.
Publicado: (2021)

Extended Thromboprophylaxis in Patients with COVID-19
por: Zhao, Wei, et al.
Publicado: (2021)

The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists
por: Visser, Chantal, et al.
Publicado: (2021)

Optimal Anticoagulant Dosing in Patients with COVID-19, a Retrospective Review
por: Carrillo, Alessandra, et al.
Publicado: (2021)

Use of Defibrotide in Patients with COVID-19 Pneumonia; Results of the Defi-VID19 Phase 2 Trial
por: Ruggeri, Annalisa, et al.
Publicado: (2021)

CAN INFLAMMATORY MARKERS PREDICT THE SUCCESSFUL EXTUBATION IN PATIENTS WITH COVID-19?
por: Mughal, Mohsin, et al.
Publicado: (2020)

The prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in intensive care unit (ICU) healthcare personnel (HCP) and its implications—a single-center, prospective, pilot study
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2020)

Acute viral myositis complicated by rhabdomyolysis: a sole manifestation of COVID-19 infection
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2021)

Pantoea agglomerans Bacteremia: Is It Dangerous?
por: Kaur, Ikwinder Preet, et al.
Publicado: (2020)

Rapid ECMO Training for Nurses in Response to the COVID-19 Pandemic
por: Toy, B., et al.
Publicado: (2021)

COVID-19 patients in a tertiary US hospital: Assessment of clinical course and predictors of the disease severity
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2020)

Role of Direct Oral Anticoagulants for Post-operative Venous Thromboembolism Prophylaxis
por: Tun, Han Naung, et al.
Publicado: (2022)

RESPIRATORY RATE – OXYGENATION (ROX) INDEX CORRELATION WITH HIGH-FLOW NASAL CANNULA OUTCOME IN COVID-19 RESPIRATORY FAILURE: A SINGLE CENTER EXPERIENCE
por: KRAMER, VIOLET E., et al.
Publicado: (2022)

Cerebral Venous Sinus Thrombosis in COVID-19: An Unusual Presentation
por: Kaur, Ikwinder, et al.
Publicado: (2021)

692. Secondary Infections and Coinfections in Coronavirus Disease 2019 (COVID-19)
por: Kaur, Ikwinder P, et al.
Publicado: (2020)

Is There any Additional Benefit of Multiple Doses of Tocilizumab in COVID-19 Patients?
por: Mughal, Mohsin S, et al.
Publicado: (2020)

IMMUNE THROMBOCYTOPENIA PURPURA FLARE POST SARS-COV-2 VACCINATION
por: Ali, Elrazi, et al.
Publicado: (2021)

Hard Palate Perforation in an Elderly Man With Dementia
por: Mughal, Mohsin S, et al.
Publicado: (2021)

E-cigarette or vaping product use associated lung injury, (EVALI) - A diagnosis of exclusion
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2020)

Perioperative Anticoagulation Management in Spine Surgery: Initial Findings From the AO Spine Anticoagulation Global Survey
por: Louie, Philip, et al.
Publicado: (2020)

A Review of Left Ventricular Non-compaction Cardiomyopathy (LVNC)
por: Mirza, Hasan, et al.
Publicado: (2022)

Hypertension as an Independent Risk Factor for In-Patient Mortality in Hospitalized COVID-19 Patients: A Multicenter Study
por: Mirza, Hasan, et al.
Publicado: (2022)

Impact of colchicine on mortality and morbidity in COVID-19: a systematic review
por: Sanghavi, Devang, et al.
Publicado: (2022)

The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound
por: Wainberg, Mark, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ct8fm5ri30mpl6idnrc2mo8e8l